RxDoctor Payments DataLook up a doctor →

Graeme Archer, MD

Family Medicine · Bentonville, ARNPI 1326240797

Payments from drug & device makers

$13,393in general payments, 2019–2025

Across 948 payments — averaging $14.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$1K
  • AstraZeneca$1K
  • GSK$1K
  • Novo Nordisk$913
  • Lilly USA, LLC$894
  • plus $6K from 51 others

What the payments were for

  • Food & beverage$13,382100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)159$1,886
Pfizer100$1,170
AstraZeneca39$1,139
GSK95$1,001
Novo Nordisk63$913
Lilly USA, LLC64$894
Amgen50$848
Abbott50$591
Johnson & Johnson49$530
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$390
Boehringer Ingelheim20$351
Bayer16$307
Astellas Pharma US Inc18$293
Merck16$245
Amarin Pharma, Inc.12$232
Kowa Pharmaceuticals America, Inc.17$218
Sumitomo Pharma America, Inc.15$191
Exact Sciences9$154
Biohaven Pharmaceuticals, Inc.10$148
Teva Pharmaceuticals USA, Inc.8$138
Takeda Pharmaceuticals U.S.A., Inc.11$128
Mylan Specialty L.p.8$128
Esperion Therapeutics, Inc.8$102
Alfasigma USA, Inc.6$98
E.r. Squibb & Sons, L.L.C.7$94
Novartis7$89
Biohaven Pharmaceutical Holding Company Ltd.6$86
Dexcom, Inc.5$82
Radius Health, Inc.5$81
Dynavax Technologies Corporation5$74
Sanofi-aventis U.S. LLC6$71
Sanofi Pasteur Inc.3$63
Stryker1$59
Phathom Pharmaceuticals, Inc.4$55
Avanir Pharmaceuticals, Inc.4$52
Eisai Inc.3$48
Arbor Pharmaceuticals, Inc.2$41
Vanda Pharmaceuticals Inc.2$37
Genentech USA, Inc.2$28
Amneal Pharmaceuticals LLC2$28
Therapeuticsmd, Inc.2$27
Sunovion Pharmaceuticals Inc.2$26
Lundbeck LLC1$25
Daiichi Sankyo Inc.1$24
Averitas Pharma Inc.1$23
Inspire Medical Systems, Inc.1$20
Travere Therapeutics, Inc.1$19
Antares Pharma, Inc.1$18
Supernus Pharmaceuticals, Inc.1$18
Bausch Health US, LLC1$17
Viatris Specialty LLC1$16
Exeltis, USA Inc.1$16
Ironshore Pharmaceuticals Inc.1$14
Currax Pharmaceuticals LLC1$13
Dermira, Inc.1$12
Idorsia Pharmaceuticals US Inc1$12
Ironwood Pharmaceuticals, Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,393 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$118,426
Medicare patients
393
Services billed
7,649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban163$138,416
JardianceEmpagliflozin66$82,835
OzempicSemaglutide54$80,607
Trelegy ElliptaFluticasone/Umeclidin/Vilanter78$69,360
JanuviaSitagliptin Phosphate55$55,403
XareltoRivaroxaban56$49,943
MounjaroTirzepatide35$44,255
TrulicityDulaglutide16$25,761
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$22,609
MyrbetriqMirabegron29$22,423
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr45$21,582
Tresiba Flextouch U-100Insulin Degludec21$9,530
Repatha SureclickEvolocumab17$9,422
LinzessLinaclotide11$6,720
SymbicortBudesonide/Formoterol Fumarate18$5,488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$1,170$141,788174 claims
GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta$1,001$95,980138 claims
Boehringer IngelheimJardiance$351$82,83566 claims
Novo NordiskOzempic$913$80,60754 claims
Lilly USA, LLCMounjaro, Trulicity$894$70,01651 claims
MerckJanuvia$245$55,40355 claims
Johnson & JohnsonXarelto$530$49,94356 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,139$28,09845 claims
Astellas Pharma US IncMyrbetriq$293$22,42329 claims
AbbVieLinzess, Synthroid$1,886$8,66141 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$28$2,678469 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Bentonville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →